Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis.

Journal of Cancer Epidemiology
Haojie LiJeanenne J Nelson

Abstract

Comorbidity influences screening practice, treatment choice, quality of life, and survival. The presence of comorbidities and medication use could place patients at greater risks of adverse effects from certain interventions. We conducted a longitudinal cohort study in the General Practice Research Database to better understand comorbidities and medication use in men with or at risk of prostate cancer (CaP). Compared with men with similar age but no CaP, CaP patients had higher incidence of urinary tract infection, impotence and breast disorder, and 2.6-fold higher all-cause mortality. Among men with elevated prostate-specific antigen (PSA) but no CaP, the mortality rates were slightly lower, and fewer differences in comorbidities and medication use were noted compared to men without elevated PSA. Many prevalent comorbidities and medications were consistent across groups and are typical of an older male population. These real-world data are broadly applicable throughout the drug development cycle and subsequent patient management.

References

Sep 1, 1996·Annals of Epidemiology·R YancikB K Edwards
Dec 26, 2001·Journal of the National Cancer Institute·L C HarlanR A Stephenson
Apr 12, 2002·The New England Journal of Medicine·Colin B BeggPeter T Scardino
Nov 25, 2003·The Journal of Urology·Maxwell V MengPeter R Carroll
Jul 7, 2005·JAMA : the Journal of the American Medical Association·Ian M ThompsonCharles A Coltman
Oct 11, 2005·Critical Reviews in Oncology/hematology·S HoutermanJ W W Coebergh
Mar 7, 2006·The Journal of Urology·Paige L MarrPeter R Carroll
Jan 19, 2007·International Journal of Cancer. Journal International Du Cancer·Lonneke V van de Poll-FranseHarm R Haak
Apr 23, 2008·American Journal of Clinical Pathology·Annalisa AltimariMichelangelo Fiorentino
May 29, 2008·British Journal of Cancer·E ReamA Richardson
Jun 10, 2008·International Journal of Radiation Oncology, Biology, Physics·Floortje MolsLonneke V van de Poll-Franse
Nov 18, 2008·The Journal of Urology·Fritz H SchröderNeil Fleshner
Mar 20, 2009·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN PLCO Project Team
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Dec 2, 2009·Cancer Causes & Control : CCC·Richard M MartinPål Romundstad
Jan 15, 2010·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Herta H ChaoWm Kevin Kelly

❮ Previous
Next ❯

Citations

Oct 2, 2019·European Journal of Drug Metabolism and Pharmacokinetics·Christian ZurthHille Gieschen
May 26, 2017·Health Information Management : Journal of the Health Information Management Association of Australia·Adam Jose HodgkinsStephen Barnett
Jun 1, 2013·Biological Research for Nursing·Shannon Ruff DirksenMichael J Belyea
Feb 20, 2021·Prostate Cancer and Prostatic Diseases·Daniel E SprattKara Olivier

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.